
Revenue of $33.2M missed the $35.1M consensus. Akoya integration costs ran $2.1M, above the $1.5M modeled. Full-year guidance held at $140-145M. Shares hit a five-month low.
Quanterix shares dropped 8% after the diagnostics company reported second-quarter revenue that missed analyst estimates and warned that integration costs from its Akoya acquisition would pressure margins through the end of the year.
The company posted revenue of $33.2 million, below the $35.1 million consensus compiled by Bloomberg. The shortfall came from its core Simoa platform, where consumables sales grew 12% year-over-year but fell short of internal forecasts, Chief Financial Officer Vandana Sriram said on the earnings call.
Quanterix repeated its full-year revenue guidance of $140 million to $145 million, a range that implies second-half acceleration of roughly 15% at the midpoint. Several analysts on the call pressed management on the timing, given the first-half run rate of about $64 million.
The Akoya acquisition, which closed in April, contributed $3.8 million in revenue during the quarter. Integration costs ran $2.1 million, higher than the $1.5 million the company had modeled, Sriram said. She attributed the overrun to IT system migration and facility consolidation in the Boston area.
Gross margin came in at 56.2%, down from 61.4% a year earlier, reflecting product mix and the lower-margin Akoya business. The company expects margins to trough in the third quarter and recover to about 59% by the fourth quarter, Sriram said.
Chief Executive Officer Brian Blaser, who took over in February, said the company's sales force restructuring is largely complete and that the pipeline for new Simoa placements is the strongest it has been in three years. Quanterix placed 37 new instruments in the quarter, up from 29 a year ago.
Operating expenses rose 18% to $27.4 million, driven by Akoya-related headcount additions and higher stock-based compensation. The company reported a net loss of $9.8 million, or 26 cents per share, compared with a loss of $6.2 million, or 17 cents per share, in the same quarter last year.
Cash and equivalents totaled $244 million as of June 30, down $14 million from the prior quarter. The company said it expects to be cash-flow positive by the fourth quarter of 2025.
Quanterix shares closed at $12.41, their lowest since March. The stock has lost 34% this year.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.